MGI PHARMA, INC. Reports Fourth Quarter And Full Year 2006 Financial Results

MINNEAPOLIS--(BUSINESS WIRE)--MGI PHARMA, INC. (NASDAQ:MOGN), a biopharmaceutical company focused in oncology and acute care, today reported financial results for the three months and full year ended December 31, 2006.
MORE ON THIS TOPIC